Send to

Choose Destination
Int J Pharm Investig. 2011 Jan;1(1):29-34. doi: 10.4103/2230-973X.76726.

Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques.

Author information

Department of Pharmacy, Faculty of Technology, Osmania University, Hyderabad, India.



Efavirenz is the preferred nonnucleotide reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. It is orally active and is specific for human immunodeficiency virus type 1. Its effectiveness can be attributed to its long half-life, which is 52-76 h after multiple doses. The drug is having poor water solubility. The formulation of poorly soluble drug for oral delivery will be one of the biggest challenges for formulation scientists in the research field. Among the available approaches, the solid dispersion technique has often proved to be the most commonly used method in improving dissolution and bioavailability of the drugs because of its simplicity and economy in preparation and evaluation.


Solid dispersions were prepared by solvent evaporation and physical mixture methods by using polyethylene glycol as the hydrophilic carrier and PEGylated product was also prepared. The prepared products were evaluated for various parameters, such as polymer interaction, saturation solubility study, and drug release studies. The drug release data were analyzed by fitting it into various kinetic models.


There is an improvement in the dissolution from 16% to 70% with solid dispersion technology. Higuchi model was found to be the best fit model.


Solid dispersion is the simple, efficient, and economic method to improve the dissolution of the poorly water-soluble drugs.


BCS class II drugs; polyethylene glycol; solvent evaporation method

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center